Our Mission
Our goal is to help millions of cluster headache patients access safe, effective pain relief treatments as soon as possible. Their pain cannot go unnoticed for one more day.
Psychedelics such as psilocybin, LSD, and DMT are highly effective, yet the vast majority of patients cannot access them legally. Many patients have opted to break local laws by treating their excruciating pain with psychedelics. We hope to help end this crisis.
To achieve our mission, we:
- Publish open letters demanding that governments, regulatory bodies, and medical associations worldwide take action immediately.
- Engage with policymakers globally to advocate for better access to treatments.
- Publish research on cluster headache and support other researchers in the field.
- Collaborate with entrepreneurs and philanthropists motivated to bring effective treatments to market.
Organizations
ClusterFree is an initiative of the Qualia Research Institute.
We also collaborate closely with Clusterbusters and the Organisation for the Prevention of Intense Suffering, who have been at the forefront of cluster headache advocacy for years.
Team
Dr. Alfredo Parra
Co-Founder & Director
Andrés Gómez Emilsson
Co-Founder & Member of Advisory Board
Bob Wold
Member of Advisory Board
Dr. Jonathan Leighton
Member of Advisory Board
Our Partners
A global network of organizations supports ClusterFree's mission. Get in touch to list your organization as a partner and show your solidarity.
Donate
ClusterFree is ready to scale our impact, and we can absorb additional funding to execute our roadmap. Get in touch if you would like to learn more about our plans.
You can donate via card, bank transfer, PayPal, Google Pay, crypto, stocks, DAF, or Venmo. Donations are tax-deductible in the US.
We also strongly recommend donating to Clusterbusters. For over 25 years, Clusterbusters has been the driving force behind psychedelic treatments for cluster headache, turning anecdotal patient reports into peer-reviewed medical research. They have directly helped thousands of cluster headache patients worldwide, and their website is the most comprehensive resource for cluster headache patients seeking information about existing and emerging treatments.
Additionally, consider supporting the Organisation for the Prevention of Intense Suffering. Beyond publishing academic and policy papers, their advocacy work resulted in Health Canada granting a cluster headache patient legal access to psilocybin for the first time in 2024. You can learn more about their work here.
Every day of delay means more patients suffer in silence. Your donations can change that. Thank you for your support!
Get Involved
Patients, medical experts, policymakers, and anyone motivated to help can make a difference. Contact us discuss how you can get involved.